RNS Number : 1709L
Personal Group Holdings PLC
04 September 2023
 

4 September 2023

Personal Group Holdings plc

("the Company" or "Group")

Notice of Results

 

Personal Group Holdings Plc (AIM: PGH), the workforce benefits and services provider, will announce its Interim Results for the six months ended 30 June 2023 on 29 September 2023.

 

-ENDS-

 

 

For more information please contact:

 

 

 

Personal Group Holdings Plc

 

Paula Constant (CEO) / Sarah Mace (CFO)

Via Alma PR

 

 

Cenkos Securities Plc

 

Camilla Hume / Callum Davidson (Nomad)

+44 (0)20 7397 8900

Jasper Berry (Sales)




Alma PR

+44 (0)20 3405 0205

Caroline Forde / Joe Pederzolli / Kinvara Verdon

personalgroup@almapr.co.uk 

 

 

Notes to Editors

 

Personal Group Holdings Plc (AIM: PGH) is a workforce benefits and services provider. The Group enables employers across the UK to improve employee engagement and support their people's physical, mental, social and financial wellbeing. Its vision is to create a brighter future for the UK workforce.

 

Personal Group provides health insurance services and a broad range of employee benefits, engagement, and wellbeing products. Its offerings can also be delivered through its proprietary app, Hapi, and the recently developed extension to the platform, Hapiflex.

 

The Group's growth strategy is centred around widening the footprint of the business into the SME, talent-led & Public Sectors, thereby expanding the addressable customer base. In addition, it aims to grow in its existing industrial heartlands, to re-invigorate growth in insurance policyholders and to drive the use of its SaaS offerings.

 

Group Clients include: Airbus, Barchester Healthcare, British Transport Police, Merseyrail, Randstad, Royal Mail Group, The Royal Mint, the Sandwell & Birmingham NHS Trust, Stagecoach Group plc, and The University of York.

 

For further information on the Group please see www.personalgroup.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORUASOROSUKRAR